or
forgot password
  • cancer clinical trials in chapel hill, NC

  • Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2
    University of North Carolina, Chapel Hill
    Chapel Hill, North Carolina 27599
    Prostate Cancer
    Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab
    North Carolina Cancer Hospital at U of North Carolina at CH
    Chapel Hill, North Carolina 27599
    Lung Cancer
    Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers
    UNC Center for Environmental Medicine, Asthma and Lung Biology
    Chapel Hill, North Carolina 27599-7310
    Smoking
    E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Patients With Hepatocellular Carcinoma
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Hepatocellular Carcinoma
    Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer
    Lineberger Comprehensive Cancer Center, University of North Carolina
    Chapel Hill, North Carolina 27599
    Breast Neoplasms, HER2 Protein, Human, Geriatric Health Services
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599
    Prostatic Neoplasms
    Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
    University of North Carolina Hospitals
    Chapel Hill, North Carolina 27599
    GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
    Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Colorectal Cancer Metastatic
    Study of BKM120 or BEZ235 and Capecitabine in Patients With Metastatic Breast Cancer
    Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599-7305
    Metastatic Breast Cancer
    Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Bacterial Infection, Mucositis, Neutropenia
    Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Squamous Cell Carcinoma of the Head and Neck
    A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
    UNC Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina
    HER-2 Positive Breast Cancer
    Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Breast Cancer
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Fungal Infection, Leukemia, Neutropenia
    Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer, Metastatic Breast Cancer
    Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Graft Versus Host Disease, Systemic Scleroderma
    Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects
    Lineberger Comprehensive Cancer Center, UNC
    Chapel Hill, North Carolina 27599-7295
    Non Small Cell Lung Cancer (NSCLC)
    Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
    The University of North Carolina - Department of Anesthesiology
    Chapel Hill, North Carolina 27599
    Pain
    PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Recurrent Neuroblastoma
    Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Metastatic Melanoma
    Reduced Intensity Conditioning Versus Myeloablative Conditioning for Acute Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)
    University of North Carolina Hospital at Chapel Hill
    Chapel Hill, North Carolina 27599
    Leukemia, Myelocytic, Acute
    Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Who Are Light or Never Smokers
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Lung Cancer
    Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
    Unc Aids Crs (3201)
    Chapel Hill, North Carolina 27516
    HIV-1 Infection
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
    UNC Health Care, NC Cancer Hospital
    Chapel Hill, North Carolina 27514
    Urothelial Carcinoma
    Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
    GTx Investigative Site
    Chapel Hill, North Carolina 27514
    Muscle Wasting, Non Small Cell Lung Cancer
    Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
    GTx Investigative Site
    Chapel Hill, North Carolina 27514
    Muscle Wasting, Non-Small Cell Lung Cancer
    A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001 AM4)
    Call for Information (Investigational Site 0018)
    Chapel Hill, North Carolina 27514
    Tumor, Solid
    Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
    University of North Carolina Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Metastatic Pancreatic Adenocarcinoma
    Neoadjuvant Pazopanib in Renal Cell Carcinoma
    North Carolina Cancer Hospital (UNC)
    Chapel Hill, North Carolina 27599
    Renal Cell Carcinoma
    Zarnestra in Newly Diagnosed Acute Myelogenous Leukemia (AML)With 2 Gene Expression Signature Ratio
    UNC-Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Acute Myelogenous Leukemia
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Endometrial Cancer
    Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Prostate Cancer
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Racial Disparity in Barrett's Esophagus
    University of North Carolina Chapel Hill
    Chapel Hill, North Carolina
    Barrett's Esophagus, Gastroesophageal Reflux Disease (GERD), Intestinal Metaplasia
    MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Acute Myeloid Leukemia
    Randomized Phase II Study of Single Agent OSI-906 Versus Topotecan for Relapsed Small Cell Lung Cancer (SCLC)
    UNC Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina
    Lung Cancer
    Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Colorectal Carcinoma, CRC
    MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab & Vincristine
    Division of Hematology-Oncology, UNC Chapel Hill Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, Mantle Cell Lymphoma, Burkitt's Lymphoma
    Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
    University of North Carolina
    Chapel Hill, North Carolina 27599
    B-cell Childhood Acute Lymphoblastic Leukemia, Peripheral T-cell Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma, T-cell Childhood Acute Lymphoblastic Leukemia
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    University of North Carolina
    Chapel Hill, North Carolina 27599
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
    University of North Carolina, Chapel Hill
    Chapel Hill, North Carolina 27599
    Tumors, Medical Oncology, Neoplasms
    Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Von Willebrand Disease
    Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Head and Neck Cancer
    Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Cervical Cancer, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexuality and Reproductive Issues
    Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer, Metastatic Gallbladder Cancer, Recurrent Adult Primary Liver Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    Radiation Therapy in Treating Patients With Prostate Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexual Dysfunction
    Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Breast Cancer
    Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
    UNC - Chapel Hill
    Chapel Hill, North Carolina 27599
    Solid Tumour, Adenocarcinoma of the Colorectal, Adenocarcinoma of the Pancreas
    Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
    University of North Carolina Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Neoplasm
    Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Childhood Cerebral Astrocytoma/Malignant Glioma, Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Infratentorial Ependymoma, Childhood Mixed Glioma, Childhood Oligodendroglioma, Childhood Supratentorial Ependymoma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma
    Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212
    Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599-7305
    Breast Cancer
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Breast Cancer
    GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
    Univ. of North Carolina
    Chapel Hill, North Carolina 27599
    Breast Cancer, Brain Metastases
    Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Lung Cancer
    Patient Preferences for Breast Reconstruction After Mastectomy
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Breast Cancer
    Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
    University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Advanced Adult Hepatocellular Carcinoma
    Telemonitoring Study - for Chronic Myeloid Leukemia (CML)
    UNC Healthcare
    Chapel Hill, North Carolina 27599
    Chronic Myeloid Leukemia
    Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Thyroid Cancer, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Metastatic Colorectal Cancer, Colorectal Cancer
    A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.
    University of North Carolina Medical Center
    Chapel Hill, North Carolina
    Metastatic Pancreatic Adenocarcinoma, Pancreatic Cancer, Metastatic Pancreatic Cancer
    Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Colon Cancer, Rectal Cancer